Malignant astrocytic glioma: genetics, biology, and paths to treatment
- PMID: 17974913
- DOI: 10.1101/gad.1596707
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Abstract
Malignant astrocytic gliomas such as glioblastoma are the most common and lethal intracranial tumors. These cancers exhibit a relentless malignant progression characterized by widespread invasion throughout the brain, resistance to traditional and newer targeted therapeutic approaches, destruction of normal brain tissue, and certain death. The recent confluence of advances in stem cell biology, cell signaling, genome and computational science and genetic model systems have revolutionized our understanding of the mechanisms underlying the genetics, biology and clinical behavior of glioblastoma. This progress is fueling new opportunities for understanding the fundamental basis for development of this devastating disease and also novel therapies that, for the first time, portend meaningful clinical responses.
Similar articles
-
Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.Br J Neurosurg. 2009 Aug;23(4):351-63. doi: 10.1080/02688690903158809. Br J Neurosurg. 2009. PMID: 19637006 Review.
-
Therapeutic strategies for inhibiting invasion in glioblastoma.Expert Rev Neurother. 2009 Apr;9(4):519-34. doi: 10.1586/ern.09.10. Expert Rev Neurother. 2009. PMID: 19344303
-
Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma.Cold Spring Harb Symp Quant Biol. 2008;73:421-6. doi: 10.1101/sqb.2008.73.005. Epub 2008 Nov 6. Cold Spring Harb Symp Quant Biol. 2008. PMID: 19022744 Review.
-
Emerging role of new transgenic mouse models in glioma research.Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S7-13. doi: 10.1586/14737140.7.12s.S7. Expert Rev Anticancer Ther. 2007. PMID: 18076321 Review.
-
Biology and treatment of malignant glioma.Semin Oncol. 2000 Jun;27(3 Suppl 6):1-10. Semin Oncol. 2000. PMID: 10866344 Review.
Cited by
-
Bulk and single cells transcriptomes with experimental validation identify USP18 as a novel glioma prognosis and proliferation indicator.Exp Ther Med. 2024 Mar 26;27(5):229. doi: 10.3892/etm.2024.12517. eCollection 2024 May. Exp Ther Med. 2024. PMID: 38596661 Free PMC article.
-
The Potential Role of the Extracellular Matrix Glycoprotein Reelin in Glioblastoma Biology.Pharmaceuticals (Basel). 2024 Mar 21;17(3):401. doi: 10.3390/ph17030401. Pharmaceuticals (Basel). 2024. PMID: 38543187 Free PMC article.
-
Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized Cell Lines, and on C. elegans.Int J Mol Sci. 2024 Mar 12;25(6):3226. doi: 10.3390/ijms25063226. Int J Mol Sci. 2024. PMID: 38542198 Free PMC article.
-
Dysregulation of LINC00324 promotes poor prognosis in patients with glioma.PLoS One. 2024 Mar 26;19(3):e0298055. doi: 10.1371/journal.pone.0298055. eCollection 2024. PLoS One. 2024. PMID: 38530810 Free PMC article.
-
Glioblastoma Therapy: Past, Present and Future.Int J Mol Sci. 2024 Feb 21;25(5):2529. doi: 10.3390/ijms25052529. Int J Mol Sci. 2024. PMID: 38473776 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases